Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome
🤖AI Özeti
A long-standing campaign has led to the renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). This change, resulting from extensive global consultation, aims to reduce confusion and alleviate the suffering associated with the previous name. The condition affects approximately one in eight women, impacting an estimated 170 million women worldwide.
💡AI Analizi
📚Bağlam ve Tarihsel Perspektif
Polycystic ovary syndrome has long been a misunderstood condition, often leading to misdiagnosis and inadequate treatment. The name change to PMOS reflects a growing recognition of the need for clarity and sensitivity in medical terminology, particularly for conditions that predominantly affect women. This initiative is part of a broader movement to empower patients and advocate for their needs within the healthcare system.
This article is for informational purposes only and does not constitute medical advice. Always consult a healthcare professional for medical concerns.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.